Table 1 and Table S1 report patient and donor characteristics including: type of disease (acute lymphoblastic leukemia, ALL, or acute myeloid leukemia, AML), presence, and type of donor NK alloreactivity, KIR genotype, B content value, and patient clinical outcome. Here, KIR3DL1 is linked to acute myeloid leukemia.